Cart
sales@molnova.com
TLR7/8-IN-1
CAS No. 2205095-75-4
TLR7/8-IN-1( —— )
Catalog No. M35003 CAS No. 2205095-75-4
TLR7/8-IN-1, a crystalline TLR7/TLR8 inhibitor from patent WO2019220390 (compound 2b), is a valuable compound for autoimmune disease research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 287 | Get Quote |
|
| 5MG | 455 | Get Quote |
|
| 10MG | 682 | Get Quote |
|
| 25MG | 1122 | Get Quote |
|
| 50MG | 1555 | Get Quote |
|
| 100MG | 2043 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTLR7/8-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionTLR7/8-IN-1, a crystalline TLR7/TLR8 inhibitor from patent WO2019220390 (compound 2b), is a valuable compound for autoimmune disease research.
-
DescriptionTLR7/8-IN-1 is a crystalline from of a TLR7/TLR8 inhibitor extracted from patent WO2019220390, compound 2b. TLR7/8-IN-1 can be used for the research of autoimmune disease.
-
In VitroTLR7/8-IN-1 is a crystalline from of a TLR7/TLR8 inhibitor. TLR7/8-IN-1 can be used for the research of autoimmune disease.
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetTLR
-
RecptorTLR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2205095-75-4
-
Formula Weight532.68
-
Molecular FormulaC29H40N8O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 12.5 mg/mL (23.47 mM; Ultrasonic )
-
SMILESCc1nn(CC23CCC(CC2)(CC3)NC(=O)[C@@H]2COCCN2)c2CCN(Cc12)c1cc(C)nc2n(C)ncc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. WO2019220390
molnova catalog
related products
-
Imiquimod
Imiquimod is an immune response modifier that acts as a toll-like receptor 7 agonist.
-
Imiquimod 2HCl
Imiquimod 2HCl is a toll-like receptor 7 (TLR7) agonist and an immunomodulator with antiviral and antitumor activity.
-
BBIQ
BBIQ is a powerful vaccine adjuvant that enhances innate immune responses and it is a imidazoquinoline compound and a potent and selectively toll-like receptor 7 (TLR7) agonist with an EC50 of 59.1 nM for human TLR7.
